AIGH Capital Management as of Dec. 31, 2020
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 45 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Cohu (COHU) | 9.0 | $22M | 580k | 38.18 | |
O2micro International Limite Spons Adr | 6.8 | $17M | 1.8M | 9.18 | |
Blue Bird Corp (BLBD) | 6.1 | $15M | 819k | 18.26 | |
Cloudera | 5.7 | $14M | 1.0M | 13.91 | |
F5 Networks (FFIV) | 5.4 | $13M | 75k | 175.94 | |
Ford Mtr Co Del Call Call Option | 5.4 | $13M | 1.5M | 8.79 | |
Avaya Holdings Corp | 5.1 | $13M | 660k | 19.15 | |
Emcore Corp Com New (EMKR) | 5.1 | $13M | 2.3M | 5.45 | |
Coherent | 4.8 | $12M | 79k | 150.02 | |
Nautilus (BFXXQ) | 4.8 | $12M | 651k | 18.14 | |
Aspen Aerogels (ASPN) | 4.4 | $11M | 656k | 16.69 | |
Ocean Bio-Chem | 3.3 | $8.2M | 612k | 13.36 | |
Lightpath Technologies Com Cl A (LPTH) | 3.0 | $7.3M | 1.9M | 3.92 | |
Ideal Pwr Com New (IPWR) | 2.5 | $6.2M | 754k | 8.17 | |
Mirum Pharmaceuticals (MIRM) | 1.9 | $4.8M | 275k | 17.46 | |
Paratek Pharmaceuticals | 1.9 | $4.7M | 750k | 6.26 | |
Vanda Pharmaceuticals (VNDA) | 1.9 | $4.6M | 350k | 13.14 | |
Catalyst Pharmaceutical Partners (CPRX) | 1.8 | $4.5M | 1.4M | 3.34 | |
Strongbridge Biopharma Shs Usd | 1.7 | $4.3M | 1.8M | 2.43 | |
Adamas Pharmaceuticals | 1.5 | $3.8M | 876k | 4.33 | |
Annovis Bio (ANVS) | 1.4 | $3.5M | 464k | 7.54 | |
Scpharmaceuticals (SCPH) | 1.4 | $3.4M | 637k | 5.29 | |
Myomo Com New (MYO) | 1.2 | $2.9M | 434k | 6.73 | |
9 Meters Biopharma | 1.1 | $2.7M | 3.1M | 0.86 | |
Catalyst Biosciences Com New | 1.1 | $2.7M | 421k | 6.31 | |
Allena Pharmaceuticals | 1.0 | $2.6M | 2.0M | 1.28 | |
Rigel Pharmaceuticals Com New (RIGL) | 1.0 | $2.5M | 702k | 3.50 | |
Alimera Sciences Com New (ALIM) | 0.9 | $2.1M | 501k | 4.22 | |
Aridis Pharmaceuticals Incorporated (ARDS) | 0.9 | $2.1M | 347k | 6.07 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.8 | $2.1M | 399k | 5.17 | |
Aviat Networks Com New (AVNW) | 0.8 | $2.0M | 59k | 34.15 | |
Hepion Pharmaceuticals | 0.8 | $2.0M | 923k | 2.19 | |
Pixelworks Com New (PXLW) | 0.8 | $1.9M | 667k | 2.82 | |
Cyclo Therapeutics *w Exp 11/14/202 (CYTHW) | 0.6 | $1.5M | 350k | 4.35 | |
Cyclo Therapeutics Com New (CYTH) | 0.6 | $1.5M | 350k | 4.35 | |
Theratechnologies | 0.6 | $1.4M | 577k | 2.50 | |
Salarius Pharmaceuticals Com New | 0.6 | $1.4M | 1.5M | 0.91 | |
Cellectar Biosciences *w Exp 04/20/202 | 0.5 | $1.2M | 583k | 2.11 | |
Energy Focus | 0.5 | $1.1M | 280k | 4.03 | |
Endra Life Sciences | 0.4 | $975k | 1.3M | 0.75 | |
Data I/O Corporation (DAIO) | 0.3 | $820k | 199k | 4.12 | |
Acer Therapeutics | 0.3 | $656k | 251k | 2.62 | |
Key Tronic Corporation (KTCC) | 0.1 | $327k | 47k | 6.90 | |
Panbela Therapeutics | 0.1 | $320k | 90k | 3.56 | |
Vuzix Corp Com New (VUZI) | 0.1 | $238k | 26k | 9.10 |